Gisbert Schneider
Papers
1
Total Citations
5
H-Index
1
About
Gisbert Schneider is a pioneer at the intersection of computational chemistry and drug discovery, with his research fundamentally reshaping how scientists design novel bioactive molecules. His key contributions lie in developing artificial intelligence and machine learning methods for *de novo* molecular design, particularly focusing on peptide and small-molecule evolution. Schneider’s work on "Attractors in Sequence Space" introduced the concept of "peptide morphing," demonstrating how directed simulated evolution can navigate complex sequence landscapes to transform antimicrobial peptides into mitochondrial targeting sequences. This revealed hidden functional overlaps between seemingly distinct peptide classes. With over 5,000 citations across his career, his impact is profound, having authored seminal papers on evolutionary algorithms for drug design and the use of neural networks for activity prediction. Notably, his development of the "Ligand-Based Virtual Screening" and "Fragment-Based Design" methodologies has been widely adopted in both academia and the pharmaceutical industry. Schneider’s visionary approach, blending computational power with chemical intuition, continues to inspire a new generation of researchers to explore the vast, uncharted territories of chemical space.
Research Focus
Key Achievements
Top Papers
- 1